← Evidence map

ArticleEMBO reports2024

NME4 mediates metabolic reprogramming and promotes nonalcoholic fatty liver disease progression.

Shaofang Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38177901